ATE282691T1 - Chemokin typ cc-ahnliches protein - Google Patents

Chemokin typ cc-ahnliches protein

Info

Publication number
ATE282691T1
ATE282691T1 AT96932016T AT96932016T ATE282691T1 AT E282691 T1 ATE282691 T1 AT E282691T1 AT 96932016 T AT96932016 T AT 96932016T AT 96932016 T AT96932016 T AT 96932016T AT E282691 T1 ATE282691 T1 AT E282691T1
Authority
AT
Austria
Prior art keywords
protein
transformant
chemokine
chemokine type
dna
Prior art date
Application number
AT96932016T
Other languages
English (en)
Inventor
Toshio Imai
Tetsuya Yoshida
Osamu Yoshie
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26396957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE282691(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE282691T1 publication Critical patent/ATE282691T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96932016T 1995-09-27 1996-09-27 Chemokin typ cc-ahnliches protein ATE282691T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24945795 1995-09-27
JP5604496 1996-03-13
PCT/JP1996/002801 WO1997011969A1 (fr) 1995-09-27 1996-09-27 Proteine analogue a la chemokine de type cc

Publications (1)

Publication Number Publication Date
ATE282691T1 true ATE282691T1 (de) 2004-12-15

Family

ID=26396957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96932016T ATE282691T1 (de) 1995-09-27 1996-09-27 Chemokin typ cc-ahnliches protein

Country Status (11)

Country Link
US (1) US6793917B1 (de)
EP (1) EP0860446B1 (de)
JP (1) JP3996191B2 (de)
KR (1) KR100514015B1 (de)
CN (1) CN1253471C (de)
AT (1) ATE282691T1 (de)
AU (1) AU711626B2 (de)
CA (1) CA2233207C (de)
DE (1) DE69633866T2 (de)
ES (1) ES2233978T3 (de)
WO (1) WO1997011969A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US6498015B1 (en) 1995-06-07 2002-12-24 Icos Corporation Methods of identifying agents that modulate the binding between MDC and an MDC receptor
US6737513B1 (en) 1996-06-07 2004-05-18 Icos Corporation Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same
WO1997029192A1 (en) * 1996-02-12 1997-08-14 Schering Corporation Mammalian dendritic cell chemokine reagents
US6812004B1 (en) 1996-02-12 2004-11-02 Schering Corporation Mammalian dendritic cell chemokine reagents
WO1998007862A2 (en) * 1996-08-23 1998-02-26 Human Genome Sciences, Inc. Chemokine beta-16
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6488930B1 (en) 1999-01-15 2002-12-03 Millennium Pharmaceuticals, Inc. Anti-CCR4 antibodies and methods of use therefor
US6245332B1 (en) 1999-01-15 2001-06-12 The Board Of Trustees Of The Leland Stanford Junior University Modulation of systemic memory T cell trafficking
EP1050307A1 (de) * 1999-05-06 2000-11-08 Applied Research Systems ARS Holding N.V. CCR4 Antagoniste in Sepsis
CN1244584A (zh) 1999-05-14 2000-02-16 北京医科大学 具有免疫细胞趋化和造血刺激活性的趋化因子
NZ542784A (en) * 2002-08-19 2008-07-31 Astrazeneca Ab Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
CN100357323C (zh) * 2006-01-05 2007-12-26 清华大学 一种细胞迁移相关蛋白及其编码基因与应用
JPWO2023286821A1 (de) * 2021-07-15 2023-01-19
WO2025205534A1 (ja) * 2024-03-25 2025-10-02 積水メディカル株式会社 免疫測定方法、精度管理方法、標準試料及び免疫測定試薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029192A1 (en) * 1996-02-12 1997-08-14 Schering Corporation Mammalian dendritic cell chemokine reagents
WO1998007862A2 (en) * 1996-08-23 1998-02-26 Human Genome Sciences, Inc. Chemokine beta-16

Also Published As

Publication number Publication date
US6793917B1 (en) 2004-09-21
KR100514015B1 (ko) 2006-01-27
DE69633866T2 (de) 2005-11-10
DE69633866D1 (en) 2004-12-23
EP0860446A1 (de) 1998-08-26
CN1253471C (zh) 2006-04-26
JP3996191B2 (ja) 2007-10-24
KR19990063764A (ko) 1999-07-26
CA2233207A1 (en) 1997-04-03
AU711626B2 (en) 1999-10-21
WO1997011969A1 (fr) 1997-04-03
CN1202906A (zh) 1998-12-23
EP0860446B1 (de) 2004-11-17
AU7096396A (en) 1997-04-17
CA2233207C (en) 2011-05-03
EP0860446A4 (de) 2000-02-02
ES2233978T3 (es) 2005-06-16

Similar Documents

Publication Publication Date Title
ATE282691T1 (de) Chemokin typ cc-ahnliches protein
ATE153068T1 (de) Interleukin-4-rezeptoren
IL88472A0 (en) Mammalian interleukin-1 receptor protein dnas and expression vectors encoding them,processes for producing them and pharmaceutical compositions containing them
DK0460846T3 (da) Type II interleukin-1-receptorer
DE69632658D1 (de) Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
LU90591I2 (fr) Enbrel-etanercept
IL83192A (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
ATE140009T1 (de) Interleukin-4 protein mit bcgf- und tcgf- aktivität gegenüber menschlichen zellen (menschliches interleukin-4)
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
AU5411398A (en) Novel polypeptide, novel DNA, and novel antibody
FI103987B1 (fi) Interleukiini-7
DE69016508D1 (de) Interleukin-7-Rezeptoren.
DE68922582D1 (de) Klonierung und Expression eines Proteins, das die zellulare Reaktion auf Interferon vom Typ I moduliert.
EP0255320A3 (de) Herstellung von Proteinen in Myelomazellen
JPS6463394A (en) Novel chimera polypeptide
ZA875267B (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties